Cam Gallagher - Jan 4, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role
Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Stock symbol
OCUP
Transactions as of
Jan 4, 2023
Transactions value $
$0
Form type
4
Date filed
1/6/2023, 08:00 AM
Previous filing
Nov 15, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Exercise of in-the-money or at-the-money derivative security $0.16 +1.57K +6.74% $0.00* 24.9K Jan 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCUP Series B Warrant (right to buy) Exercise of in-the-money or at-the-money derivative security $0 -1.57K -100% $0.00* 0 Jan 4, 2023 Common Stock 1.57K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrants has been exercised in full.